Trial Profile
Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 05 Dec 2012 Planned number of patients (20) added as reported by European Clinical Trials Database.
- 05 Dec 2012 Planned number of patients (20) added as reported by European Clinical Trials Database.
- 16 Sep 2010 New trial record